Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T17:05:45.239Z.
Calculation as of: 2026-10-06T17:05:45.239Z.
Quote observation: 2026-10-06T17:00:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6ebf84f3f464cb4543e326b3b96959337d3a5891063dc6ef63f2f1a4491a7a3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$1.50M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.38M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.34M | N/A | N/A | N/A | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | N/A | 7.22x | 7.22x | 7.22x |
| NEXGEL, Inc. (NXGL)vs › | $1.43M | N/A | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.32M | N/A | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.27M | N/A | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.47M | N/A | 56.09x | 56.09x | 56.09x |
| PMGC Holdings Inc. (ELAB)vs › | $1.48M | N/A | N/A | N/A | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | N/A | 8.03x | 7.79x | 7.79x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
